Cytolon AG - Deutsches Eigenkapitalforum

Transcription

$EUTSCHES¬%IGENKAPITALFORUM
w%NTREPRENEURSåMEETåINVESTORSi
Top 50 capital seeking companies
Company
Page
healthy planet
AE Photonics GmbH
118
Henan Snow Bird
REVOTAR Biopharmaceuticals AG
157
Affimed Therapeutics AG
119
Enterprise Co., Ltd
138
RIEMSER Arzneimittel AG
158
AMEOS AG
120
ibidi GmbH
139
Sana Kliniken AG
159
Inventux Technologies AG
140
SemiLev GmbH
160
ANM Adaptive
137
Platin Delikatessmanufaktur GmbH 156
Neuromodulation GmbH
122
Jedox AG
141
Signature Diagnostics AG
161
Armatix GmbH
123
JPK Instruments AG
142
SIRION BIOTECH GmbH
162
Atlas Interactive Deutschland GmbH 124
Lophius Biosciences GmbH
143
SUNOVA AG
163
Aupeo GmbH
125
Maxidor (Pty) Ltd
144
Superwise Technologies AG
164
BIOMETRY.com AG
126
MCW Oil Sands Recovery, LLC
145
Targos Molecular Pathology GmbH 165
Breezecom Inc.
127
Medicyte GmbH
146
Torqeedo GmbH
Concentrator Optics GmbH
128
166
Metasonic AG
147
van den Berg AG
167
CPM Compact Power Motors GmbH 129
Micropelt GmbH
148
VESTOLIT GmbH & Co. KG
168
Curetis AG
130
mimoOn GmbH
149
VST Verbundschalungstechnik
Cytolon AG
131
mitcaps GmbH
150
GmbH – VST Group
169
MOBILES REPUBLIC
151
Windreich AG
170
Bank in Gründung
132
Ningbo Strong Magnets Co., Ltd.
152
Zimory GmbH
171
evidanza GmbH
133
Novaled AG
153
finocom AG
134
NTS Energie- und
friedola TECH GmbH
135
Transportsysteme GmbH
154
froodies GmbH
136
Omikron Data Quality GmbH
155
Deutsche Revo AG |
Capital Seeking Companies
AE Photonics GmbH
Renewable Energies
Profile
Business Field
Year of establishment
Number of employees
Equity (in m€)
Financing needs (in m€)
Positive result since
Revenues in 2009 (in m€)
Revenues in 2011e (in m€)
2008
45
6
10
2008
43
93
85
110
AE Photonics GmbH specialises in the trade of photovoltaic
components along the value chain. Aside from the core
business of trading, AE Photonics Group also realises solar
parks and photovoltaic power plants in major plant engineering up to several megawatts. In the trade of photovoltaic components as well as in the project business,
AE Photonics works with products of well-known manufacturers of solar modules, inverters and substructures.
Strategic Market Position
Contact
Contact person
Phone
E-mail
Website
Address
Gunnar Anger
+49-(0) 3 51-31 58 07-23
[email protected]
www.ae-photonics.com
Loschwitzer Str. 37
01309 Dresden
Germany
The markets being currently mostly relevant for AE Photonics are Germany and Italy being sales markets for wholesaling and construction. Greece and Morocco will follow.
Management
Marco Lamsouguer, CEO
He originates from real estate financing. From 2007 until the
incorporation of AE Photonics he managed the department
Alternative Energies at a privately owned company. He
founded AE Photonics Group in November 2008.
Gunnar Anger, CFO
As a trained banker, Mr. Anger studied BA and worked as
an investment banker in the fields of corporate finance,
equity financing and M&A, where he was responsible for
several capital market transactions for German small and
medium-sized companies. He joined AE in September 2010.
Gunnar Anger, CFO
Martin Attenhauser, CSO
Martin Attenhauser, CSO
Martin Attenhauser worked for 5 years as senior asset manager with Hudson Advisors Germany GmbH / Lone Star
Funds. Beforehand he was a consultant for the law firm
Walter & Walter in the area of Corporate Restructuring. Mr.
Attenhauser studied industrial engineering and BA. In September 2010 he joined AE.
Planned Investment, Shareholders/Investors
Privately owned so far
Investments of around 10 m€
Page 118
Deutsches Eigenkapitalforum 2011
Affimed Therapeutics AG
Biotechnology
Profile
Number of employees
Equity (in m€)
2000
30
7.8
25
3
5
and auto-immune indications. The company is focussing on
two liquid cancer indications, Non-Hodgkin- and Hodgkin’s
disease addressing unmet medical needs in both indications and attractive market potentials.
Management
Affimed is led by an internationally experienced management team with extensive experience in the pharmaceutical
and biotech industries: Dr. Rolf H. Günther, CEO; Prof. Dr.
Melvyn Little, CSO; Dr. Florian Fischer, CFO; Dr.
Miroslav Ravic, CMO; Dr. Adi Hoess, CCO.
Contact
Website
Address
www.affimed.com
Im Neuenheimer Feld 582
69120 Heidelberg
Germany
Business Field
Dr. Adi Hoess, CCO
Affimed is an innovation driven biotech company very
strongly positioned in antibody therapeutics – the fastest
growing segment of the pharmaceutical industry – and has
pursued a focussed strategy of developing human antibodies as therapeutics. By utilizing its broad portfolio of proprietary, in-house technology platforms together with crucial enabling freedom-to-operate licenses, the company has
been able to establish an early stage and clinical product
pipeline of promising novel product candidates focussed
on oncology. Affimed has its lead product in advanced Phase I clinical stage with a CD30xCD16a Tandab – Antibody targeting Hodgkin’s disease.
Dr. Florian Fischer, CFO
We are backed by a peer group of investors including
Orbimed, Aeris, LSP, BioMed Invest and Novo Nordisk A/S.
The company is currently raising up to 25 m€ in a Series D
financing, of which 13 are currently committed.
Affimed has developed a novel bi-specific antibody technology. The antibodies are suited to be applied in oncological
Deutsches Eigenkapitalforum 2011 Page 119
AMEOS AG
Healthcare
Profile
Business Field
Number of employees
Equity (in m€)
2002
7000
100
200
2008
336
356
394
410
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Volker Wendel
+41-(0) 8 78 35-33 66
[email protected]
www.ameos.eu
Bahnhofplatz 14
8021 Zürich
Switzerland
The AMEOS business model includes the acquisition, the
reorganisation as well as the sustainable management of
hospitals and long-term care facilities. AMEOS operates in
four business lines: AMEOS acute general hospitals,
AMEOS acute psychiatric hospitals, AMEOS long-term
elderly care and AMEOS long-term mental care. AMEOS
provides healthcare services for the general public and
focusses on major regional medical centres offering various
specialties. AMEOS is a major private operator of psychiatric facilities in Europe with broad expertise in the field of
operating forensic hospitals. The elderly and mental care
facilities of AMEOS complement the integrated healthcare
approach of an AMEOS Region.
AMEOS is among Europe’s leading health service providers, focussing mainly on German-speaking regions.
AMEOS hospitals and long-term care facilities offer highquality and cost-effective medical and nursing services,
combining inpatient and outpatient services in regional networks – the AMEOS regions. With this integrative business
model AMEOS stands out from its competitors. Following a
growth strategy, AMEOS aims to establish new healthcare
regions and expand existing ones. AMEOS has become a
highly distinctive brand in the healthcare market.
Management
The AMEOS group is lead by a management team of five:
Dr. Axel Paeger (CEO), Dr. Volker Wendel (CFO), Michael
Dieckmann (COO), Dr. Stephan Zahn (CTO) und Dr. Marina Martini (CDO).
From left to right: Dr. Stephan Zahn, Dr. Marina Martini, Dr. Axel Paeger,
Michael Dieckmann, Dr. Volker Wendel
Page 120
Institutional investors with a long-term investment horizon
such as pension funds and life insurances make the majority of the shareholders; furthermore the members of the
management team are personally invested. Because
AMEOS follows a growth strategy, future growth will require
both private and debt capital.
ANM Adaptive
Neuromodulation GmbH
Medical Technology
Profile
Number of employees
Equity (in m€)
2005
21
6.0
3.0
0.001
2.3
1.2
4.8
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Jörg Stein
+49-(0) 2 21-4 54-63 01
[email protected]
www.anm-medical.com
Im Mediapark 6d
50670 Köln
Germany
huge market. The neurostimulator is approved as a medical
device for commercialisation in Europe and has been marketed
in Germany since 2010 and in four other European countries
as from 2011. Filing for U.S. FDA-approval was done.
10-20% of Parkinson’s patients suffer from the late-dopa
syndrome: drugs no longer help. This is the target group for
treatment with deep brain stimulation. ANM has developed
an implant that is due to be transferred in a first human
application in 2012 to confirm long-term therapy success
with minimal side effects. The latter already was demonstrated in animal experiments and in acute human applications. ANM has the potential to come up with a breakthrough innovation in a fast-growing billion-dollar market.
Management
ANM is led by an experienced management team and
advisory team.
Business Field
ANM is a start-up, spun off from Forschungszentrum
Jülich. Its scientifically developed technology platform has
potential to generate benefits in various medical fields
(such as Tinnitus, Parkinson’s, Chronic Pain, ADHD, or
Movement Disorders after Stroke). Pioneering work in
neuromodulation devices has been developed to reduce
the disease symptoms, initially focussing on two projects,
an auditory tinnitus neurostimulator and a deep brain
stimulation implant for Parkinson’s treatment.
The basic technology (coordinated reset, CR) is widely protected by world-wide patents. ANM has shown that CR can
reduce Tinnitus by acoustic stimulation (with about 70%
treatment success). Since there is no treatment standard and
no established treatment method, CR addresses a potentially
Page 122
Dr. Jörg Stein, CEO
Jukka Schnitzler, CFO
ANM is a technology leader in the field of neural stimulation.
The successful development and market introduction of the
advanced CR technology allows entry into billion-markets
with products which might be „game-changing . With the
universal approach of having a platform technology further
treatments can be developed, e.g. in Chronic Pain, Migraine, Movement Disorders after Stroke, Dystonia or ADHD. In
order to complete the developments and to conduct the
necessary clinical studies in the next two years, about 3 m€
are required. According to conservative planning, the
break-even will be achieved by then. ANM is currently
financed via 25 private investors and the KfW.
Armatix GmbH
Industrial Products & Services
Profile
Number of employees
Equity (in m€)
Business Field
2004
30
5.0
0.190
0.260
1.400
7.900
Locking Systems for Weapons
Technology leader in mechatronic locking systems for
weapons
Management
Bernd Dietel, Ernst Mauch, Günter Hefner,
Franz Hermann
Contact
Contact person
Phone
E-mail
Website
Address
Günter Hefner
+49-(0) 89-4 27 29 79-0
[email protected]
www.armatix.de
Feringastr. 4
85774 Unterföhring
Germany
Bernd Dietel
Ernst Mauch
Günter Hefner
Franz Hermann
Approx. 5 m€
Bernd Dietel, Ernst Mauch, Mountain Partners, KfW
Atlas Interactive
Deutschland GmbH
Telecommunication Services
Profile
Management
Number of employees
Equity (in m€)
1995
30
0.5
5.0
2007
15
21
30
45
The management consists of 5 persons:
Marco Priewe, CEO: More than 15 years of management
experience in telecommunications. Has been honorary
member of the Board of Directors of the DVTM, the German
Association for Telecommunication and Media, for more
than 10 years.
Andreas Syska-Funk, CIO, Ingo Vahl, CFO, Andreas
Pritzlaff, COO, and Lars Ketelsen, CMO.
Contact
Contact person
Phone
E-mail
Website
Address
Marco Priewe
+49-(0) 40-41 33 00-1 15
[email protected]
www.atlasinteractive.de
Christoph-Probst-Weg 3
20251 Hamburg
Germany
Business Field
AI is the provider of kanzaloo™, a unique micro payment
solution, allowing merchants to monetize on digital goods
and virtual currency. Kanzaloo™ allows payment transactions in 85 countries without unveiling any personal data.
Since 2001, ATLAS Interactive is owned to 100% by ATLAS
Interactive Holdings Ltd, a 90% daughter company of the
ATLAS Group of Companies. This group is owned to 90%
by Mr. Jean Michel Alfieri and Mr. Philippe Bednarek.
The mission of AI is to become the leading global provider
of micro payment solutions for the distribution of digital
goods. Raising external funds of approx. 5.0 m€ shall help
AI to realize the existing growth strategy. It is the declared
goal to reach an annual turnover of above 400 m€ by 2015.
The funds shall mainly be used for the following purposes:
Foundation of international subsidiaries, increase of human
development resources, external IT developments, e-wallet
functionality and acquisition of small e-money license, expansion of sales and marketing activities, development of
additional B2C and affiliation strategy, product improvements, etc.
AI is leading provider of micro payment solutions in Europe,
serving companies such as Bigpoint, Gameforge, Frogster,
Travian Games, Aeria Games, Innogames, NDR Media,
Deutsche Telekom, Sport 1, Playa Games etc. AI has 28 employees located in Hamburg (HQ) and Cologne. In March
2010, AI opened an office in San Francisco, another office is
scheduled to open in Indonesia end of 2011. The company is
profitable since 2007 and reaches annual growth rates of
30–50%.
Page 124
Marco Priewe, CEO
Aupeo GmbH
Communications Technology
Profile
Number of employees
Equity (in m€)
Management
2008
30
0.9
5-6
2012
0.1
0.250
0.500
7.0
Holger G. Weiss, CEO
Armin G. Schmidt, COO
Steffen Holly, CTO
Daniel Cox, Head of Sales
Daniel Mieves, Head of Marketing
Talip Yenal, Head of Finance
Contact
Contact person
Phone
E-mail
Website
Address
Holger G. Weiss
+49-(0) 30-4 00 05 68-0
[email protected]
www.aupeo.com
Alexanderstr. 7
10178 Berlin
Germany
Holger G. Weiss, CEO
Armin G. Schmidt, COO
Business Field
AUPEO is specialized in personalized music stream in the
web, on apps and on internet capable devices. The global
services allow users to create their own Music DNA and to
discover music they really like
- JCMB, Hamburg
- Ventegis Capital, Berlin
- IBB Beteiligungsgesellschaft, Berlin
- Kfw, Bonn
- Innoven Partners, Paris
AUPEO is the leading music service on internet capable
devices. On more than 25 million devices like netbooks,
laptops, TVs, smartphones, HIFI etc., the service can be
accessed all over the world. AUPEO is also leading partner
to the automotive industry. In 2010 they launched for MINI
the first streaming service in a serial car ever.
AUPEO is venture capital backed. So far the following
funds have invested:
AUPEO is seeking to close a Series C round by end of 2011
over 6 m€.
BIOMETRY.com AG
IT-Services
Business Field
Profile
Biometric Authentication
Number of employees
Equity (in m€)
2006
4+5
2.5
1.5
2013
0.1
1++
Contact
Contact person
Phone
E-mail
Website
Address
Werner Blessing
+41-(0) 79-4 34 45 35
[email protected]
www.biometry.com
Chilcherlistr. 1
6055 Alpnach - Luzern
Switzerland
More security is needed, because of increased cybercrime.
PINs and tokens are insecure. The biometric passports
bring a strong growth into this market segment.
BIOMETRY.com AG invented a solution called ComBiom
(Communication Biometrics), which uses four biometrics (biometric face, voice, word recognition and
recognition of lip movement) simultaneously. Four randomly selected numerals appear successively on the
display and the user speaks these numerals. Internet
and mobile applications are uniquely secured against
replay and spoofing attacks. An international research
group shows the importance; BIOMETRY is a member of
the www.tabularasa-euproject.org.
MOBILE AUTHENTICATION: a pilot will start in Q1-2012 in
partnership with www.access-company.com (ACCESS has
1 billion customers worldwide).
PHYSICAL ACCESS: in cooperation with www.bioguard.net
applicable biometric door openers with the trademark
BIOMETRY will be introduced to the market.
LOGICAL ACCESS: Werner Blessing presents possibilities
of Logical Access to the „Deutsche Bank in December `11.
Further contacts are being made with the Swiss banks.
AFFILIATES: in Estonia, Shanghai. To come: Munich, Tel
Aviv, Cape Town, California, etc.
Management
Werner Blessing, CEO, Herbert Lüthold, CTO, Martin
Aschwanden, CFO
Werner Blessing, CEO
Money for development of the authentication products is
needed.
Further for sales and marketing.
Page 126
Breezecom Inc.
Profile
Number of employees
Equity (in m€)
2007
90
1.0
15.0
2007
20.75
37.01
35.0
50.0
Breezecom’s strategic geographic locations in the Middle
East & Asia Pacific has enabled strong strategic deals with
major telecom companies in the region. It controls about
20% of the voice traffic into Pakistan and significant traffic
to Bangladesh & India. Focus has always been on countries
where the outward immigration pattern is strong, and hence
core destinations like Pakistan, India, Bangladesh, Srilanka
have been a success story for Breezecom. Having
established itself in Asia, the group now aims to explore
countries in Latin America, Africa & Europe.
Management
Contact
Website
Address
www.breezecom.biz
Level 1, Lot 7, Block F,
Saguking Commercial Building,
Jalan Patau-Patau
87000 Labuan FT
Malaysia
Business Field
Breezecom is one of the leading providers of international
wholesale voice aggregation services in the Middle East
and the Indian Sub-Continent. Using its carrier-grade telecom infrastructure, it provides voice calls routes to telecom
companies around the globe that enable them to offer international calling services to their subscribers, e.g. Telecom
Italia would use Breezecom to carry their subscribers’ international voice traffic around the world. Breezecom enjoys
strategic interconnects with over 500 telecom providers,
deals in over 25 major destinations, and processes over
two billion minutes of voice traffic each year. It uses intelligent technologies in order to efficiently manage large
volumes with minimum human interaction. Building its own
organic voice traffic has also been managed successfully
by the group.
Breezecom
was
founded by Silicon
Valley
veterans,
Afaque Ahmed &
Yasin Altaf, who
have taken this
venture from a two
man company to
over 35 m€ revenues
Afaque Riaz Ahmed
Yasin Altaf
in 5 years. Mr. Riaz
has extensive experience in technical marketing and sales
roles in networking technologies, while Mr. Altaf enjoys
valuable experience in defining and successfully launching
bleeding edge telecom products at startup companies.
Both of them are serial technology entrepreneurs and have
other successful ventures under their belts. The dynamic
duo is popular for its vision and attention to detail in the
technology arena. Breezecom’s finance is currently being
headed by Mr. Faisal Muqeet, ACMA.
The company is privately funded by the two founders. They
are the only shareholders sharing the equity 50/50. The
group now plans to expand its services in different countries in Latin America, Africa & Europe. The capital raised
will be used primarily for the development of telecom infrastructure, establishment of manned offices, targeted
acquisitions, hiring seasoned management staff, and
working capital to secure strategic deals.
Concentrator Optics GmbH
Renewable Energies
Profile
SOG), and the only one to offering both processes as turnkey supplier to her customers.
Number of employees
Equity (in m€)
2008
12
0.58
3.5 bis 5.0
2013
0.3
0.4
0.7
3.5
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Ralf Leutz
+49-(0) 64 21-16 89 40-0
[email protected]
www.concentratoroptics.com
Lahnstr. 16
35091 Cölbe
Germany
Business Field
Management
Concentrator Optics was founded in 2008 by Dr. Ralf Leutz
and Rainer Adomeit. Ralf Leutz has been working on Fresnel lenses and solar applications for over 15 years. He accompanied several solar projects from research to production. Dr. Leutz is the author of the book „Nonimaging
Fresnel lenses – Design and performance of solar concentrators (Springer 2001), and a respected expert in the
developing market of CPV.
Rainer Adomeit complements the technology as experienced Shareholder and Managing Director of several companies. His responsibilities at Concentrator Optics are marketing, sales and finances.
The Financing Round C is designed to ensure and press
ahead the growth of Concentrator Optics. Investments will
flow in equal parts into an automated production line and
expanding personnel capacity around the world.
Principal shareholders are the founders Dr. Ralf Leutz and
Rainer Adomeit, as well as the Capricorn Cleantech Fund,
Leuven, Belgium.
Concentrator Optics is the one-stop turn-key provider of
technologies empowering Fresnel lens production. We offer
optical design, prototyping and manufacturing of Fresnel
lenses for concentrating photovoltaics (CPV) as well as
complete turn-key production lines.
The market volume for solar optics in CPV is estimated to
exceed 500 m€ in 2015. These optics will be nonimaging
Fresnel lenses in large-area Fresnel lens parquets of highest transmittance. Traditional optics makers do not produce
such lens parquets as they have specialized on other materials, processes and small size units. There are 5 companies
worldwide producing Fresnel lenses for CPV. Concentrator
Optics is the only company supporting both processes
customary in the market (PMMA and silicone-on-glass,
Page 128
Dr. Ralf Leutz
Rainer Adomeit
CPM Compact Power Motors GmbH
Energy Efficiency & Reduction of Emission
Profile
Number of employees
Equity (in m€)
2008
15
n/a
n/a
n/a
n/a
0.65
1.0
3.5
• Far East markets with already large sales volumes of gasoline powered and electric two-wheelers such as China
and India
With a strong network of experienced professionals, development associates and manufacturing partners, as well as
leading investor support from the „Cleantech sector, CPM
is a flexible, reliable and innovative partner for electrical
drive solutions.
Contact
Contact person
Phone
E-mail
Website
Address
MBA Christian Kasten
+89-(0) 2 87 24 68-52
[email protected]
www.cpmotors.eu
Feringastr. 11
85774 Unterföhring
Germany
Nico Windecker
Christian Philip Kasten
Business Field
Management
CPM develops and manufactures the world’s most efficient
and compact drive solutions – all „Made in Germany . Our
compact, high-performance drive units couple a brushless
synchronous motor with a fully integrated control unit, provide powers ranging from 500 W to 100 kW and are particularly well suited for all types of vehicle and battery-driven
applications as well as for all energy recovery tasks.
Dr. Ing. Thomas Leiber, Aerospace & Electrical Engineer,
Founder and Chairman
Nico Windecker, Attorney, Founder & CEO
Dipl.-Ing. Thomas Simonis, Electrical Engineer, Head of R&D
Christian Philip Kasten, MBA, CFO
Lead Investor Munich Venture Partners with Co-Investor
KfW, Environmental Technologies Fund (UK), IP GATE AG
Zurich, Nico Windecker, Founder
CPM offers fully integrated drive train systems, particularly
in the fields of electric two-wheelers and auxiliary power
units such as AC compressors and pumps.
CPM sales activities are focussed on two main geographical areas:
• European countries with established, high volume two
wheeler market and relatively high price levels
Curetis AG
Medical Technology
Business Field
Profile
Number of employees
Equity (in m€)
2007
30
6.7
10
2
Molecular Diagnostics / Med Tech
Curetis develops the Unyvero platform and solution to
diagnose acute infectious diseases by identifying pathogens as well as antibiotic resistances.
The first product application is for the diagnosis of 17
pathogens and 22 antibiotic resistance markers for pneumonia in hospitalized patients.
Clinical Trial stage company with a proprietary platform with
unmatched multiplexing capabilities.
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Oliver Schacht
+49-(0) 70 31-4 91 95-12
[email protected]
www.curetis.com
Max-Eyth-Str 42
71088 Holzgerlingen
Germany
Curetis is building a marketing and sales organization for its
home markets in Germany, Austria and Switzerland (DACH)
and will rely on distributors and strategic partners to commercialize the Unyvero solution globally.
Management
Oliver Schacht, CEO
Andreas Boos, CTO
Johannes Bacher, COO
Anne Burger, CFO
Raised over 27 m€ of capital from top European VC investors (aeris Capital, LSP Life Science Partners, BioMed Partners, CD-Venture, KfW). Several private angel investors.
Series A financing completed
Oliver Schacht, CEO
Page 130
Johannes Bacher, COO
Curetis targets an additional financing round in late 2011 to
fully fund our clinical trials in EU and USA towards an FDA
approval.
Cytolon AG
Biotechnology
Profile
Number of employees
Equity (in m€)
2008
15
2.8
5.0
2013
1.5 (e)
Cytolon is now working on the next generation of platform
technology for „distributed inventories as an approach to
include and match additional stem cell products via donor
registries or inventories of the pharmaceutical industry. In a
strategic deployment, the company sees an opportunity for
a second innovative matching product. Cytolon will adapt
its proprietary IT-platform to enable more efficient and
effective partnering and acquisitions between players in
drug development. Cytolon’s objective is to be the world’s
first trusted source for partnering opportunities on the web.
Contact
Contact person
Phone
E-mail
Website
Address
Thomas Klein
+49-(0) 30-2 63 92 88-0
[email protected]
www.cytolon.com
Am Karlsbad 15
10785 Berlin
Germany
Thomas Klein, CEO
Business Field
Management
Cytolon AG is a private company based in Berlin, Germany,
that develops and operates proprietary, global, internetbased brokering platforms to address challenges of personalized medicine and innovative drug development. The
company’s first product is the patent-pending CordMatch®
platform which was developed to enable the matching of
available cord blood units to Leukaemia patients requiring a
transplant. This market is the first existing market of personalized medicine.
Thomas Klein, Founder & CEO of Cytolon AG. He focusses
on the company’s strategy, business development and
marketing of the matching platform CordMatch®. With more
than 20 years of professional experience as an entrepreneur, he has a proven track record in biotechnology and IT.
Dr. Jeanette Libera-Körner, Biophysics, MBA – Vice President Research & Development
Isabel Feys, MBA – Vice President Partnering
Ralf Schliehe-Diecks, M. Sc. – Vice President IT Systems
With CordMatch® Cytolon provides solutions and services
for today and the future, so world-wide transplant centers
(TC) and physicians can talk actively and effectively to
world-wide cord blood banks (CBB), registries, industry
partners and service providers.
5 m€ for strategical imperative investment, Dr. Jürgen
Schumacher, Co-Founder of QIAGEN AG, further investors
are family funds in Switzerland and Germany as well as KfW
Bankengruppe.
Deutsche Revo AG
Bank in Gründung
Other Banks
Profile
Number of employees
Equity (in m€)
1998
6
1
15
1998
153
147
2
175
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Uwe-Peter Hastedt
+49-(0) 61 73-60 77 681
[email protected]
www.deutsche-revo.de
Hauptstr. 332
65760 Eschborn
Germany
Working capital management is a market of the future
having enormous potential in terms of business and yields.
Target customers will be the premier small to medium sized
companies with a turnover ranging from 10 m€ to 1 bn€.
Deutsche RevoBank is aiming for a business volume of
1 m€ in the medium term. As a result of the emphasis placed by Deutsche RevoBank on working capital it has a unique selling proposal within the banking sector. The focus
will be on the areas of inventories and commodities, where
a substantial competitive advantage exists. Deutsche
RevoBank will revolutionize working capital management
because it optimizes and finances it at the same time.
Management
Dr. Uwe-Peter Hastedt, initiator and CEO of the Deutsche
Revo AG, jointly founded the MHB-Group and as the managing business partner built it up to a successful specialist
provider for working capital for small to medium sized
companies in Germany.
Business Field
Deutsche Revo AG is taking a completely new approach to
financing working capital (inventories, goods, accounts
receivable and tangible fixed assets). Innovative solutions
for working capital will be combined with the financial
power of a bank. Deutsche Revo AG has applied for a full
bank license and in the future will operate as the Deutsche
RevoBank. The start of business operations is planned for
2012. In the role of supplier and customer, Deutsche RevoBank is a part of the supply chain. The company brings
classic trading and service functions and combines these
with typical banking activities such as financing services.
The advantage for the customer is reduced capital commitment, increased liquidity, as well as improvement of ratings.
Deutsche RevoBank is a spin-off of the MHB-Group which
since 1998 has successfully provided innovative working
capital solutions for businesses with annual volumes of up
to 300 m€.
Page 132
Dr. Uwe-Peter Hastedt, CEO
Deutsche Revo AG has a share capital of 1 m€, totally
owned by the MHB-Group. A current increase in equity of
15 m€ for the formation of the bank (14 million NPV shares
at 1.10€) is required. Anticipated yield 8-14% p.a. additionally increased by capital appreciation of the shares.
Preferably Deutsche Revo AG is looking for investors with
2 m€ or more.
evidanza GmbH
Software
Profile
Number of employees
Equity (in m€)
2004
45
1.672
5
2012
3.314*
3.105*
3.8
7.2
Management
Thomas Gross, CEO and Founder, responsible for development, marketing and sales.
Günter Meier, CEO and Founder, responsible for finance
and administration.
Contact
Contact person
Phone
E-mail
Website
Address
evidanza is the leading platform manufacturer for companies that rely on Microsoft technologies in the client and/or
infrastructure area. evidanza’s target market is the (upper)
middle class, the Microsoft Dynamics market, defined
branch markets and for the future the „Small and Small
Middle market by using Cloud and App solutions.
Thomas Groß and Günter Meier
+49-(0) 9 41-78 49 44-31
[email protected]
www.evidanza.de
Haupstr. 27
90562 Heroldsberg
Germany
* 2009 revenues include consulting business revenues, 2010 from July onwards revenues are without revenues of consulting business (after sale of
consulting business)
Business Field
evidanza is a software developer for Business Intelligence,
Corporate Performance Management, GRC (Governance,
Risk & Compliance) and Business Process Management
solutions. The software solutions are based on a proprietary
software framework (platform). This framework supports
SaaS/AaaS, as well as cloud-based software architectures
and innovative licensing models, such as App Solutions.
evidanza’s software solutions do not only cover all the
functional requirements of controlling, but even more optimize all business processes regarding information and
communication within companies. Thus the classic business intelligence approach will extended by two key areas:
enterprise management (controlling) and business process
management.
Thomas Groß, CEO
Günter Meier, CEO
The company faces continuing growth and will require capital for internationalization and for the marketing of SaaS
and cloud-app solutions. In addition to the two founders,
investors are the S-Refit, the KfW and the BayBG.
finocom AG
Profile
Number of employees
Equity (in m€)
2007
14
0.610
2
-
Contact
Contact person
Phone
E-mail
Website
Address
Peter Nowack
+49-(0) 2 21-9 99 98 56-21
[email protected]
www.placetel.de
Merowinger Platz 1
40225 Düsseldorf
Germany
Due to increasing bandwidth and modified needs in communication behaviour, business customers are now deciding
more and more on hosted phone systems. In the private sector, VOIP-technology is already gaining in popularity. Also in
business fields there are great potentials for cloud telephony
in the core target group – enterprises with 5-100 employees
(around 2.5 million). In this particular market segment, Placetel.de is positioned as the cost leader – above competitors
offering similar services – due to its efficiently automated processes in areas such as billing, support and setup, as well as
a highly scalable telephony platform, an online sale and distribution approach and fully owned technology: Placetel.de
works with marginal costs which results in savings for its
users. Placetel.de offers hosted phone systems in two versions. Placetel FREE offers complimentary range standard
services. Placetel PROFI provides premium features and
support with a wider scope of services for a limited fee.
Placetel.de is proud to be the winner of the Mittelstandspreis
2011 , underlining its unique position in the market.
Management
Business Field
Finocom AG is one of the leading cloud specialists in Germany offering a hosted communication system for small
and medium enterprises through its product Placetel.de.
This business voice solution is based on a self-developed
and highly scalable telephony platform. Business customers
are able to obtain their complete phone system from the
Placetel cloud offering, without the costly investments of a
traditional hardware telephone system. In this way, clients
benefit from a „pay per use business model, which enables
an effective resource management. Business customers
can upgrade or downsize their hosted phone system according to their individual needs and only pay for the used telephony services. In addition to the dramatic reduction in
costs, customers also profit from a wide range of unified
communication and collaboration services which work more
efficiently in the daily business environment. More than
5.000 SMB customers use Placetel today with a staggering
number of new customers registering every day.
Page 134
The managing board of the finocom AG consists of: Peter
Nowack, CEO), Kamran Hedjrat, CTO, Italo Adami, COO,
and Markus Haas, CFO.
Peter Nowack, CEO
Markus Haas CFO
The finocom AG is funded by KfW, Platinum Ventures, Sirius
Ventures Partners and Vilitas. To strengthen its market
leadership and international reach, finocom AG regularly
reviews potential strategic partners and investors.
friedola TECH GmbH
Profile
Business Field
Number of employees
Equity (in m€)
2004
300
16
10
2011
33
45
55
65
Automotive and packaging
Strategic market position
Leading position in the field of lightweight boards
Leading position in the field of lightweight boards
Contact
Contact person
Phone
E-mail
Website
Address
Christoph-Helmut Holzapfel
+49-(0) 03 60 82-4 72 25
[email protected]
www.friedola-tech.de
Ershäuser Str. 4
37308 Geismar
Germany
Christoph Holzapfel, CEO
Werner Eisenhardt, CFO
Management
Christoph-Helmut Holzapfel, CEO
Werner Eisenhardt, CFO
Mario May
Management 10%
Wheb F Tech 90%
For growth in the markets of North America and Asia.
There is a need for funding of 20 m€.
froodies GmbH
Food
Profile
Business Field
Number of employees
Equity (in m€)
2009
6 VZ, 45 TZ
0.1
1.5
0.034
0.3
0.7
3.1
Contact
Contact person
Phone
E-mail
Website
Address
Ingo Bohg
+49-(0) 2 11-26 00 85-62
[email protected]
www.froodies.de
Worringer Platz 14
40210 Düsseldorf
Germany
froodies is an online grocery shop with a personal same day
delivery service in selected major german cities and a national and international shipping service.
froodies started its online grocery business in March 2009
as one of the early movers in the German market. The
online grocery market in Germany has recently been in
vogue by new start-up companies and big grocery retailers
as REWE und Metro. As one of the few established companies in the market, froodies has established an outstanding
webshop (www.froodies.de) with efficient logistics, a huge
number of regular customers and a quick growth both in
new customers and revenues. froodies does not build up
and control own warehouses, but instead co-operates mit
local retailers from EDEKA where out-of-store picking and
personal home delivery is organized and executed by
froodies employees. This business modell and concept is
currently unique in the German market.
Management
Ingo Bohg, responsible for marketing und online products
Lutz Preußners, responsible for assortement, expansion
and operations
To realize expansion into all major German cities, the company seeks for a series A financing round with a volumne of
1.5-2.0 m€ in March/April 2012.
Lead investors: Sirius Venture Partners, High-Tech Gründerfonds
Ingo Bohg
Page 136
Lutz Preußners
healthy planet
Food
Profile
Number of employees
Equity (in m€)
Business Field
2012
10
0.25
2.75
2012
0.3
0.9
Organic ice cream & sorbets
Fully sustainable product and service portfolio, including
city stores and solar powered production facilities.
Products are 100% organic, fair trade, gluten-free and
highly desirable.
Management
Contact
Contact person
Phone
E-mail
Website
Address
Approved management. 20 years experience in company
development, leadership and product design.
Guido Jörg
+49-(0) 6 11-7 24 93 76
[email protected]
healthyplanet.de
Wandersmannstr. 68
65205 Wiesbaden
Germany
3 m€ for production facility, machinery and PV
Henan Snow Bird
Enterprise Co., Ltd
Clothing & Footwear
Profile
Number of employees
Equity (in m€)
2001
1200
30
60
2001
15
18
27.5
43.75
The company is a member of the China Feather and Down
Industrial Association and the China National Garment Association and one of the „Top Ten Foreign Exchange-earning
Enterprises in Henan Province . The company’s eiderdown
products and garments are exported to Germany, the United
States, Russia, Japan, Taiwan and other places. Its foreign
exchange earnings are expected to reach more than 10 mUS$
in 2011. The company currently accounts for 3.2% of the
country’s eiderdown output and is expected to account for
7.6% of the domestic output of eiderdown and finished goods
after going public, ranking among the top 20 in the industry.
Contact
Management
Contact person
yang CHEN
Phone
+86-(0) 21-33 31 73 96
E-mail
[email protected]
Website
www.xueniao.com
Address
TaiQian industry zone, PuYang, HeNan
457600 HeNan
China
Business Field
Henan Snowbird Enterprise Co., Ltd covers a land of
258,000 square meters and has a floor area of 78,000 square meters. It employs more than 1,100 employees and total
assets of 265.53 mRMB. The company currently has four
eider down sorting and washing production lines that produce 1,000 tons of high-quality eiderdowns each year and
more than 1,000 Japanese high-speed sewing machines
and auxiliary equipment that design and process one million pieces of down-filled garments and bedding and other
product lines each year. It is the largest manufacturing and
processing enterprise in Henan Province that integrates
duck and goose hatching & breeding, slaughtering, processing and sales, eiderdown washing and sorting, down-filled garments, down-filled bedding and other lines of products and has the right to operate import and export.
Page 138
Mr. Yan and Mr.
Qiu are industry
experts with more
than 20 years of
experience in production operation
and business management. The company actively imCEO YAN, Changzai
COO QIU, Duoxiang
plements international standards and has successively passed ISO 9001,
ISO 14001, OHSAS 18001 and HACCP certifications. While
attaching importance to product quality, it has stepped up
efforts towards product innovation and technology innovation and actively promoted the „high-tech, high-taste, modernized and branding strategy.
The company recently purchased more than 150 mu of land
in the industry cluster zone to build a modern, high-standard
deep processing, export and production base for eiderdown
products. The project involves a total investment of 450
mRMB, including 200 mRMB in fixed assets and 250 mRMB
as working capital. Upon commencement of production, the
project will bring an annual output value of 2.2 bnRMB,
annual profits and taxes of 350 mRMB and annual foreign
exchange earnings of 50 mUS$.
ibidi GmbH
Biotechnology
Profile
Number of employees
Equity (in m€)
2001
27
1.099
4,000
2008
2.216
2.648
2.800
3.100
Management
Managing Directors:
Dr. Valentin Kahl, Production, Finances, Organisation
Dr. Roman Zantl, Sales, R&D
Contact
Contact person
Phone
E-mail
Website
Address
There are three relevant markets for ibidi:
Segment 1: Scientists in the academic field. (Total: 8 bn€ in
2010 / 25 m€ relevant for ibidi).
Segment 2: Scientists in industries (Total 6 bn€ in 2015 /
200 m€ relevant for ibidi)
Segment 3: cell-based diagnostics (9 bn€ / 2011)
Dr. Valentin Kahl
+49-(0) 89-5 20 46 17-14
[email protected]
www.ibidi.de
Am Klopferspitz 19
82152 Martinsried
Germany
Business Field
ibidi is a leading supplier for functional cell-based assays
and advanced products for cellular microscopy. ibidi is
located in Martinsried, Germany, close to Munich. The US
headquarters, ibidi LLC, is located in Verona, WI, near
Madison.
Our mission is to enable our customers to achieve outstanding success and breakthroughs in life sciences, pharma,
biotechnology and medical diagnostics. We thereby are
helping to make improvements in life possible.
Dr. Valentin Kahl
Dr. Roman Zantl
Privately owned company. Founders are still holding 65%.
Inventux Technologies AG
Renewable Energies
Profile
Number of employees
Equity (in m€)
2007
270
4.0
30-40
2010
22.5
61.6
>50
>60
range has been continuously expanded to include system
components and photovoltaic project planning services.
The Inventux Solutions GmbH has already completed turnkey photovoltaic plants with a cumulated volume of over
5 MWp. In 2010, Inventux has marketed 40 MWp and
achieved an annual turnover of 61.6 m€ and positive
EBITDA and EAT. Inventux has developed a broad range of
proprietary technology, know-how and IP. It has developed
its own back-end production line and operates independently from turn-key equipment providers. Full capacity
utilization and constant improvement of production
processes have led to competitive production costs with
the potential to further reduce costs.
Contact
Management
Contact person
Phone
E-mail
Website
Address
Oliver Rothe
+49-(0) 30-62 64 06-0
[email protected]
www.inventux.com
Wolfener Str. 23
12681 Berlin
Germany
Business Field
Inventux Technologies AG is a Germany-based developer,
manufacturer and distributor of silicon-based micromorph
thin-film solar modules focussed on the residential and commercial scale rooftop market. Inventux was founded by the
current management team in 2007 and is headquartered in
Germany which is also home to the Company’s main manufacturing facility. Inventux has built a European distribution
network with local presence in the core markets of Germany, Italy, France, Great Britain, Spain and South Europe. In
2010 Inventux has built up its own project business company offering turn-key photovoltaic plants.
Inventux markets its products directly to installation companies and developers and focusses in particular on the residential and commercial rooftop market. Inventux’ product
Page 140
Inventux relies on a
highly experienced
management team
with a long-term
track record in solar and a proven
ability to develop
within 18 months a
start-up idea into a
Oliver Rothe, CFO
Roland Sillmann, CTO
successful revenue
generating company with 270 employees. Inventux has fully implemented a
Management Information System and an SAP ERP-System
and has four testified annual financial statements. In 2009,
Inventux received ISO 9001 certification. Prerequisites for
growth have been put in place.
Inventux has a concentrated shareholder structure. Shareholders comprise the executive board the management
team, Capital Stage AG and Conetwork Erneuerbare Energien Holding GmbH. Inventux plans to further expand production with the addition of another 120 MW solar module
line to increase overall capacity to 150 MW. Total invest
volume is about 130 m€. This expansion step will reduce
production costs of the solar modules to below 0,5 €/Wp
further strengthening Inventux` competitiveness.
Jedox AG
IT-Services
Profile
Number of employees
Equity (in m€)
2002
70
1,5
k.A.
-
In the market segment of database and planning systems,
Jedox is (according to the actual BARC BI Survey) the most
innovative vendor with the lowest total costs, the highest
business achievements rate, the fastest realtime analysis
and the best support quality.
Currently more than 70 employees are working for Jedox.
The headquarters are located in Freiburg, subsidiaries exist
in Frankfurt, Hamburg and Paris. Furthermore over 50 partner companies are selling the Jedox products in Europe,
the APAC area and in North and South America.
Contact
Contact person
Phone
E-mail
Website
Address
Jochen Lachnit
+49-(0) 7 61-1 51 47-2 42
[email protected]
www.jedox.com
Bismarckallee 7a
79098 Freiburg
Germany
Business Field
Kristian Raue, CEO
Jedox is a worldwide leading vendor of in-memory-based
Business Intelligence Systems. Jedox is the pioneer in
using parallel processors (GPUs) for in-memory OLAPservers and with that provides an advantage in speed that
is up to 100 times higher than comparable systems offered
by IBM, SAP or Microsoft.
Jochen Lachnit, Vice President Finance
Management
Kristian Raue, CEO and Founder
Matthias Krämer, CTO
Bernd Eisenblätter, COO (Sales & Marketing)
The software is available as an open source as well as a
premium version and is used by more than 10.000 companies worlwide. The increase in sales of the last years has
always been in the range of 50% (exception 2009: 15%). In
the first half of 2011 a growth of more than 70% could be
realized.
More information online:
www.jedox.com/en/about-jedox/management.html
No acute funding needs, possible funding need in a range
of 5 m€ to accelerate international growth.
JPK Instruments AG
Nanotechnologie
Profile
Business Field
Number of employees
Equity (in m€)
1999
70
2
2004
8
10
12
-
Established in 1999, JPK Instruments AG is a leading
manufacturer of nano-analytical instruments on a global
scale. These instruments enable access to previously
unavailable levels of nanotechnology. The product portfolio
includes systems for a wide range of applications in the
areas of physics, chemistry and biology. JPK products are
especially applied in the research of surfaces, materialproperties and also nano-optics.
Contact
Contact person
Phone
E-mail
Website
Address
Frank Pelzer
+49-(0) 30-5 33 11 20 72
[email protected]
www.jpk.com
Bouchéstr. 12
12435 Berlin
Germany
Several times in the past years, Deloitte has named JPK as
the fastest-growing company in the sector of nanotechnology in Germany. The company commands a market
share of more than 50 percent in Germany. JPK instruments
are utilised in the most prestigious research institutes from
all over the world and will also be used by industrial companies in the future. The headquarters of JPK Instruments AG
are located in Berlin, with branches in Dresden, Cambridge
(UK), Paris, Tokyo and Singapore. Furthermore the company maintains a global distribution network.
Management
Management consists of the founding team and has many
years of experience and a high level of know-how in the
area of technology.
Frank Pelzer, CEO
René Grünberg, CFO
Torsten Jähnke, CTO
Jörn Kamps, COO
Main shareholders/funding requirements.
Management is the majority shareholder.
From left to right.: Torsten Jähnke (CTO), Frank Pelzer (CEO), Jörn Kamps
(COO), René Grünberg (CFO)
Page 142
Lophius Biosciences GmbH
Biotechnology
Profile
Number of employees
Equity (in m€)
Management
2002
19
0.8
1.5
0.1
0.03
0.1
1.0
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Michael Lutz
+49-(0) 9 41-6 30 91 97-2
[email protected]
www.lophius.de
Josef-Engert-Str. 13
93053 Regensburg
Germany
Lophius Biosciences has a very experienced management
team with proven expertise in the biotech and diagnostic
space. Dr. Michael Lutz as CEO has a well documented
track record with respect to build-up of small to medium
sized biotech companies. Additional management members include:
Dr. Ludwig Deml, CSO
Sabine Wahlländer, Head Sales & Marketing
Dr. Marcus Hämmerle, Head Technical Operations
Dr. Karl Kleine, Head Quality Management
Dr. Nadja Prang, Head Business Development
Dr. Kornelia Schlombs, Project leader Molecular Biology
Dr. Sascha Barabas, Project leader Cell Biology/Immunology
Business Field
Lophius Biosciences develops and markets innovative
T-cell-based diagnostic tests for diagnosis and therapy
control in the areas of transplantation, infectious and autoimmune diseases. The tests are based on two proprietary
technology platforms.
Dr. Michael Lutz, CEO
Lophius Biosciences intention is to become one of the
leading T-cell-based diagnostic products based on its
proprietary technology platforms with a particular focus on
Europe.
Currently Lophius is strongly supported by local investors
such as S-Refit (Lead Investor), High-tech Gründerfonds
and Bayernkapital. The company has a financing need of
about 1.5 m€ until break-even mid 2013.
Maxidor (Pty) Ltd
Manufacturing
Profile
Number of employees
Equity (in m€)
1985
300
2.5
30
2002
12
12.1
12.2
12.8
sales engineer will assess the clients need and we will manufacture the custom made products to the specific customers physical security barrier needs. We have a number of
patents and registered designs. We have an apetite for custom solutions and are experts at product development. We
are regarded as the experts in our field.
Management
Miklos Hegyi, Executive Director
Adv. Tinus E. Lotz, Legal
Tertius Venter-Davies, Executive Director
Renier Martin, Finance
Contact
Contact person
Phone
E-mail
Website
Address
Mr Miklos Hegyi
+27-(0) 11-2 84-30 00
[email protected]
www.maxidor.com
16 Arnold Street Alrode
1451 Johannesburg
South Africa
Miklos Hegyi
Adv. Tinus E. Lotz
Renier Martin
Business Field
Maxidor is in the business of marketing, sales, manufacturing and installation of physical security barriers. We have
two manufacturing factories in Johannesburg, two in
Durban and one in Cape Town South Africa. We also have a
branch in Pretoria and a world class Call Centre in Johannesburg. We are sales and marketing experts and have
developed an acute ability to target our market. We advise
clients on their security needs and manufacture custommade solutions from our range of products. We have
developed a successful sub-assembly franchise model in
Africa and have a network of franchises and agents.
Maxidor markets its range of expandable barriers, fixed
window grilles, swing gates and roller shutters to domestic
homes as well as commercial and industrial applications. A
Page 144
Maxidor has a well developed sub-assembly distribution
strategy. The strategy has been implemented successfully
in the factories in Cape Town and Durban as well as franchisees in four locations in South Africa and outside of
South Africa in Ghana and Zimbabwe. This successful
concept as well as the product range is well developed and
ready for massive expansion. Maxidor has the logistical
(Call centre in Johannesburg) and manufacturing infrastructure. Capital is required to expand this concept into the rest
of South Africa, Africa, South America (Brazil) and Europe.
Worldwide people are under threat in their homes and
places of work. This market is growing. Maxidor has had 25
years of experience in South Africa providing these
solutions to individuals, families and companies. These
principles, strategies and products have been tested and
are ready to be implemented worldwide.
Multi-Utilites
Profile
Number of employees
Equity (in m€)
2010
12
2
5
2011
0.0
0.0
2.2
12.5
Contact
Contact person
Dr. R. Gerald Bailey
Phone
+1-(0) 83 22 89 53-12
E-mail
[email protected]
Website http://mcwenergygroup.com/oilsandsllc.php
Address
334 Main Street, Suite 101
E4P 2E Shediac, New Brunswick
Canada
To date, the Utah oil sands areas have not been developed,
mainly due to America’s reliance on foreign oil imports, and
the fact that until now, an effective technology has not
emerged to safely extract oil from oil sands materials. MCW
Oil Sands Recovery, LLC is planning the development of its
Asphalt Ridge oil sands lease with its unique, environmentally-friendly, proprietary technology with impressive hydrocarbon extraction levels (up to 99%), utilizing benign solvents within a closed-loop system, resulting in no greenhouse gases and oil extraction at commercially viable production costs. The technology requires no water during the
process, and no high temperatures or high pressures are
needed. It is scalable and extremely mobile, and the technology works efficiently on a wide range of oil and sediment
types (both water-based and oil-based). The technology is
highly profitable, especially during the current high oil price
ranges. Due to its outstanding oil sands recovery technology, MCW Oil Sands Recovery, LLC believes it has the keys
of technology expertise and the capability to open vast oil
sands resources to production. The timing for the development of America’s oil sands deposits could not be better.
There is a new attitude in the U.S. Government about the
dependence on foreign oil and that America’s oil sands deposits should be developed.
Business Field
Management
MCW Oil Sands Recovery, LLC will produce and market oil
extracted from oil sands resources from its lease in Asphalt
Ridge, Utah. The Company is the sole owner of the Utah Oil
Sands Lease and possesses a proprietary oil sands extraction technology, which stands alone in the industry with
respect to environmental safety and efficiency. MCW Oil
Sands Recovery, LLC expects a rapid, profitable growth
with an excellent cash flow in a large market yearning for
domestic fuel sources.
America’s oil sands resources are primarily concentrated in
Eastern Utah. The Company currently owns the mineral
rights to 50+ million barrels of proven oil sands reserves in
the prolific Asphalt Ridge area.
Alexsandr Blyumkin, CEO,
R. Burk Adams, P.E., COO,
R. Gerald Bailey, CEO,
MCW Energy Group Ltd
R. Gerald Bailey
Planned Investment 5 m€; MCW Energy Group Ltd
Medicyte GmbH
Biotechnology
Profile
Number of employees
Equity (in m€)
2007
14
3
2
2013
0.1
0.1
0.5
technologies upcyte® and vericyte® enable to produce
novel types of healthy human primary cells which have not
been commercially available so far in scalable quantities and
of highest quality. Our lead product are standardized human
hepatocytes from different donors as the better alternative to
current in vitro ADME-Tox models. Medicyte is targeting the
fast growing markets for cells and cell systems as well as the
emerging multi-billion Euro market for regenerative medicine.
Medicyte has developed its innovative technologies to a proofof-principle stage in a variety of human primary cell types.
First revenues are generated from non-therapeutic licences
grants and R&D products (Liver, NK, Endothel etc.). Further
therapeutic applications for acute liver failure and bone regeneration are under development.
Contact
Management
Contact person
Phone
E-mail
Website
Address
Dipl.oec. Stefan Holder
+49-(0) 62 21-7 29 52-30
[email protected]
www.medicyte.com
Im Neuenheimer Feld 581
69120 Heidelberg
Germany
The Company is managed by a team with more than 60 years
of biotech, pharmaceutical industry and product development experience. Managing Directors: Dr. Joris Braspenning, Founder and CSO, Stefan Holder, Founder and CFO.
Business Field
Medicyte is a cell technology company specialized in the
controlled, scalable generation and standardization of
human primary cells. Medicyte’s vision is to establish its
unique and patent protected technology as a gold standard
and preferred source of human primary cells and human
cell-based products for research, industrial and therapeutic
applications. The Company has developed its innovative
cell proliferation technology ready for commercialization
and is now focussing on further market implementation of
new innovative cell products and ready-to-use kits.
Medicyte has developed a unique cell proliferation technology that forms the basis for novel cell-based research tools
and cell therapy products. Differentiated primary cells have
no or only limited proliferation capacities. Our proprietary
Page 146
Dr. Joris Braspenning,
CSO
Stefan Holder,
CFO
In a Series B financing round the Company intends to raise
a single-digit million Euro amount to continue the development of new products and prepare the path to further clinical applications. Of equal importance is the extension of the
production capacities as well as the expansion of the
marketing and sales activities.
Medicyte has previously secured funding from the Prinz von
Hohenzollern Capital, the KfW, from a business angel and
from public grants.
Metasonic AG
Software
Profile
Number of employees
Equity (in m€)
2004
45
8.583
ca. 10
0.927
1.95
3 to 6
6 to 12
Contact
Contact person
Phone
E-mail
Website
Address
Intelligence (rapidly making the right decisions), Real Resilience (being prepared for the unexpected), Real Enterprise
(fulfilling tasks as soon as they are needed) and Real Return
on Invest (fast and high ROI).
That`s Metasonic reality. E.g. NEC Japan was able to increase
productivity by 70% in an implemented process. Additionally,
a significant reduction of implementation and changes costs
within the IT-department could be achieved. Metasonic considers NEC (Japan), Fiducia, FI-TS, AUDI, TESAT and SAP
Research as their reference customers. To this date Metasonic has partners in Japan, Singapore, the Russian Federation,
Austria, Switzerland, the Middle East and India.
Management
Herbert Kindermann
+49-(0) 84 41-2 78 10-1 00
[email protected]
www.metasonic.de
Münchner Str. 29 - Hettenshausen
85276 Pfaffenhofen
Germany
Herbert Kindermann, CEO, since Aug. 2009 sole Board
member, appointed in 2007. Prior to that member of the board
of IDS Scheer AG. Additional management positions with
COMSOFT GmbH, IBCS S.A. (Founder and CEO with subsidiaries in Germany, Czech Republic and Slovakia), acquisition
of IBCS by IDS Scheer in May 2001. Supervisory board: Dr.
Albert Fleischmann; MSC Computer Science; Chairman of the
Supervisory Board and Founder of Metasonic AG; Hansjoerg
Baur; Investment Manager; T-Venture Holding GmbH; Deputy
Chairman; Jürgen Hopfner; Investment Manager; BayBG.
Business Field
Development and Sales of a Software Solution for dynamic
Business Process Management, based on the idea of
S-BPM, developed and patented by Dr. Albert Fleischmann. Sole focus of Metasonic is the sales of licenses.
Consulting, as well as international sales, is done through
an international partner ecosystem.
Only with the Metasonic Suite it is possible to use a single
process model (identical for business and IT) to represent
the reality of the process 1:1, and execute the process
instantly. This is unique and revolutionizes Business
Process Management as it is known to date. This is achieved
by the method of subject-oriented BPM, which was added
as a new category to the Gartner BPM Hype Cycle in 2011.
Delivered value for our customers: Real Business
Herbert Kindermann,
CEO
Dr. Albert Fleischmann,
Chairman Supervisory Board
Main investors: BayBG: 7,61%, KfW: 17,52%, T-Venture:
45,17% Rest: management, founder, employees and small
investors – planned investment: Min. of 10 m€ for the ongoing internationalization in Asia, US, Europe and further
development of the software.
Micropelt GmbH
Profile
Number of employees
Equity (in m€)
2006
22
3
0.3
0.3
0.6
1.9
Contact
Contact person
Phone
E-mail
Website
Address
Fritz Volkert
+49-(0) 7 61-15 63 37-77
[email protected]
www.micropelt.com
Emmy-Noether-Str. 2
79110 Freiburg
Germany
Millions of thermostatic heating valve actuators can be
operated from only one 6 mm^2 chip. Wireless sensor is
used as monitor or smart meter measuring temperature and
current consumption can be used from only 5 degree Celsius temperature difference. Home automation and building
technology applications offer huge potential with millions of
units per year – in Germany alone.
In the fast growing market of thermoharvesting, Micropelt
reached the highest level of industrialization, both in chip
mass production as well as application development.
Micropelts qNODE is the world’s first thermoharvesting based
wireless sensor. Many years of chip production know-how
and IP will secure it is significant competitive advantage.
Business Field
Micropelt develops and markets chip-size thermogenerators
that convert heat into milli-Watts of electrical energy. The products are manufactured on semiconductor-type mass production lines that will start its roll-out in early 2012. Economies of scale have been the driving force behind a scalable
product business model, which allows broad market penetration from industrial and commercial to the point of cost sensitive consumer applications. Increase in energy efficiency and
better resource utilization does require more and more monitoring and control of processes and facilities. Wireless sensors and actuators e.g. control heating, cooling and energy
transport and distribution. One of the biggest hurdles is the
limited lifetime of batteries when used as power supply. And
wiring cost in existing buildings and facilities can be a prohibiting factor. Micropelt products solve these problems
through recycling of waste heat as an infinite, maintenance
free, deploy-and-forget power source at minimum cost.
Page 148
Fritz Volkert, CEO
Oliver Keilhack, CFO
Management
Founder and CEO Fritz Volkert spend 15 years in the international semiconductor business;
Co-founder and CTO Dr. Joachim Nurnus (Dr. Ing) is a high
profile and leading scientist in thermoelectric since 10 years.
CFO Oliver Keilhack has 15 years international experience
in financing of start-ups und blue chips.
3 m€ to be provided to fund launching cost and expansion to
break-even in 2013; SHS Venture Capital; KFW; L-Bank
Baden-Württemberg; Goodvent; Management GbR.
mimoOn GmbH
Software
Profile
Number of employees
Equity (in m€)
2006
50
1.4
6.0
0
1.0
2.3
3.0
7.0
TTPCom, Ericsson, 15 years of Sales & Marketing Expertise,
Jan Westmeier, VP Engineering, previously with Nokia,
Ericsson, Headed the LTE pioneering team @ Nokia, Willem Mulder, VP Standards & IPs, previously with Agere,
Lucent, Ericsson, 20 years of Wireless & Silicon Expertise,
Peter Walther, VP Business Development, previously with
TTPCom, TI, 7Layers, 25 years of Wireless Expertise, René
Kantehm, VP Finance, previously with IKB AG and West LB
banks, 8 years in financial control
Contact
Contact person
Phone
E-mail
Website
Address
Prof. Dr.-Ing. Thomas Kaiser
+49-(0) 2 03-3 06 45-00
[email protected]
www.mimoon.de
Bismarckstr. 120
47057 Duisburg
Germany
Thomas Kaiser, CEO
René Kantehm
Business Field
Software licensing (upfront fee & royalties or one-time payment; evaluation, development or manufacturing license)
Investors: NRW Bank Venture Capital, Enjoy Venture, KfW,
HTGF, Vivieris, Aumenta
Market:
Focus is the LTE Software market (no application software)
Volume is greater than 1 bnUS$
Market entry is achieved, products are shipping
World leading chip and IP core partners
Management
Thomas Kaiser – CEO, Founder of mimoOn GmbH, 10
years of MIMO Expertise, Matthias Wesseling – CTO,
previously with Siemens, BenQ, 15 years of SDR Expertise,
Brian Meads, VP Sales & Marketing, previously with
mitcaps GmbH
Profile
mitcaps delivers its service portfolio on an individual
basis and scalable to the customer needs.
Number of employees
Equity (in m€)
2007
18
1.9
2010
1.26
3.1
4.5
6.9
Contact
Contact person
Phone
E-mail
Website
Address
Wilfried Röttgers
+49-(0) 61 31-9 50 19-10
[email protected]
www.mitcaps.de/
Mombacher Str. 40
55122 Mainz
Germany
Further services like consulting, Internet security, convergence solution, and overall IT services complete the portfolio.
mitcaps is the only virtual network operator focussing only
on the international operating mid-sized market in Germany
offering this individual combination of services on a worldwide basis. All vertical market sectors can benefit from
mitcaps service which is individually designed for each
customer. With the mitcaps’ technology, carriers and
service partners can extend their global reach beyond their
own footprint.
Management
Wilfried Röttgers, CEO & Founder
Michaela Pfeifer, CFO, Head of HR & Project Management
Ingo Kemper, Head of Engineering & Operations
Harry Boele, Investor Relations
Business Field
mitcaps GmbH – located in Mainz – is a virtual network
operator (VNO). As a VNO, mitcaps provides managed
data network services worldwide to medium-sized
companies and ensures their secure transfer of data and
VoIP communication based on state-of-the-art technologies from MPLS, Ethernet, IPSec, SDH to LTE.
mitcaps contracts the capacity of lines from various
telecommunication and service providers, merges the
sub networks to one homogeneous and optimized VPN
solution and enriches them with first class value-added
services.
The customer benefits from our special service features
such as single sourcing, billing, contract and inventory
management, monitoring through a single point of
contact. Through flexible and transparent business processes mitcaps always „delivers profit to its customers.
Page 150
Wilfried Röttgers, CEO
Investors: W. Röttgers, KfW, ISB, GPV Investment, Ltd
MOBILES REPUBLIC
Publishing & Printing
Profile
Number of employees
Equity (in m€)
2008
15
3
-
Contact
Website
Address
www.mobilesrepublic.com
Imm P / Bureaux du Lac II /
Rue Robert Caumond
33049 BORDEAUX
France
Mobiles Republic products capitalised on 3 trends : a) It has
never happened before in the history of civilisation that so
many people spend so much time reading so many news.
b) As any other type of content such as videos and music,
news will follow delinearisation.
c) The application eco system, based on his success on
mobile and tablet is going beyond reaching TV & PC.
Management
Gilles Raymond: from 1998 to 2005 Gilles was the CEO
and Founder at In-Fusio, a mobile technology provider that
deployed on 50 million phones worldwide.
Thierry Vazzoler: CTO of the company. He was IT Project
Manager at the N°1 ecommerce website in France.
David Finch (UK ): Business development with experience
in mobile content and Internet solutions.
Jérôme Le Feuvre: worked in 8 countries on mobile operator related activities. Recently he was heading the mobile
entertainment activities at Orange France.
Todd Mc Kellar (USA) was head of Business Dev for Hiplogic.
Business Field
Mobiles Republic is an international mobile media group
offering personalized content driven by intelligent semantic
technology. News Republic, our first product, is a personalized news client/application for mobile, tablets and TV.
Powered by our unique semantic tagging technology platform, it enables the user to build their own news and
information portal based on 150 000 specific topics or tags
they define. Today, News Republic offers more than 10,000
full news per day, in five languages globally. Top 10 best
rated News Application in Europe & US, News Republic has
been in the top 10 Android News section in US & Europe for
the last 3 months. Our second product, Appy Geek, 3
months after launch is already in the top 10 of the News
section of the android market.
Gilles Raymond, CEO
In order to consolidate our position in Europe and US,
prepare our expansion in Asia, and go beyond mobile &
tablets, we are raising money.
Ningbo Strong Magnets Co., Ltd.
Steel & Other Metals
Profile
Number of employees
Equity (in m€)
1996
400
10
100
1996
1.5
2
5
8
With our technique we could provide a variety of complicated shape and many surface treatment. Furthermore the
products can be magnetized in different direction of magnetization according to requests. Our technician could
design different magnetic applications according to customers’ applies.
Our R&D Center is dedicated to high-performance research
and development. The products are widely used in electric
automobile, wind generation, frequency conversion air
condition, nuclear magnetic resonance, CD-Rom drive,
vibrating motor, DC motor, linear motor, audio-systems,
sensor, apparatus and toys etc.
Contact
Contact person
Phone
E-mail
Website
Address
Zhengshan Sun
+86-(0) 1 50-22 09 54 10
[email protected]
www.magnets-china.com/
Qingshuipu Industry Zone, Zhenhai
315176 Ningbo
China
Our company has sales offices in Germany, USA, Canada,
Italy, Spain, India, Malaysia etc.
Management
Our company is a high-technology enterprise with research
& development ability and the permit of import & exporting.
And passed ISO-9001-2000 quality system certification.
Business Field
Ningbo Strong Magnets Co., Ltd. was established in 1996
and specialized in producing rare earth permanent magnets
and many kinds of magnetic application. The annual
throughput comes to NdFeB 1500 tons, SmCo 100 tons,
AlNiCo 500 tons, Ferrite 8000 tons.The rare earth magnets
are widely applied in auto industry, consumption electronics, wind generator, electric car etc. Since more than 98%
of the rare earth are supplied by China all over the world,
our company plays a key role as a top permanent magnet
manufacturer between the rare earth raw material supplier
and permanent magnet applicants.
The new manufacture workshop of our company will be
completed in October, 2011. On one hand, we are looking
for suitable partners who are in the area of rare earth
magnets application. On the other hand, we plan to invest
rare earth mine outside China.
Our company is one of the several manufactures in China
which is occupying the whole production chain between the
raw materal and applicable rare earth permanent magnets.
Page 152
Yuncheng Sun,
General Manager
Zhengshan Sun,
Investor Relations Manager
Novaled AG
OLED Technologie
Profile
Business Field
Number of employees
Equity (in m€)
2001
114
9.9
2011
8.3
11.2
-
Novaled AG is a world leader in the OLED (Organic Light
Emitting Diode) field and specializes in high efficiency long
lifetime OLED structures and is an expert in organic electronics. The company is known for its Novaled PIN OLED®
technology, its proprietary OLED materials and customized
OLED products and services. Novaled has developed long
term partnerships with major OLED producers in display
and lighting throughout the world.
Contact
Contact person
Phone
E-mail
Website
Address
Harry Böhme
+49-(0) 3 51-7 96-58 65
[email protected]
www.novaled.com
Tatzberg 49
01307 Dresden
Germany
Novaled AG is a world leader in the OLED (Organic Light
Emitting Diode) field and specializes in high efficiency long
lifetime OLED structures and is an expert in organic electronics.
Management
Harry Böhme, CFO
Gildas Sorin, CEO
Gerd Günther, CMO
Gildas Sorin, CEO
Harry Böhme, CFO
Gerd Günther, CMO
TechnoStart, Crédit Agricole Private Equity, TechFund,
CDC Innovation, eCapital, KfW, TUDAG, Dresden Fonds,
Thomson
NTS Energie- und
Transportsysteme GmbH
Renewable Energies
Profile
Number of employees
Equity (in m€)
2006
7
2.5
10
-
NTS X-Wind plants will reach a capacity of utilization of approx. 90%. The reasons for the extremly high availibilty can
be seen in the fact, that wind is more continous and stable
at higher altitude and that kites start to operate at 2 m/sec
windspeed (common windmills start at 4.5 m/sec windspeed). Therefore the investment per kWh produced per
annum with NTS power plants will be at least three times lower than with today’s windmills.
Management
Contact
Contact person
Guido Lütsch
Phone
+49-(0) 30-88 72 09 03
E-mail
[email protected]
Website
www.nts-transportsysteme.de
Address
Kurfürstendamm 217
10719 Berlin
Germany
Uwe Ahrens, Technical Director: born
1953; innovator of the idea, Aerospace
engineer (Dipl. Ing.), founder and longstanding CEO of aap Implantate AG,
IPO with aap implantate AG in 2001;
CEO of co.don AG; Committee Chairman of innovation, technology and industry of the Berlin Chamber of Industry and Commerce, board member of
the Gesundheitsstadt Berlin, among
others.
Uwe Ahrens
Business Field
NTS developed a patented and innovative wind power
plant to harness the enormous energy of wind at an altitude
of 300-500m/1.600 feet. The NTS-Concept assembles
well-known technologies to a unique and flexible wind
power plant which is able to produce baseload energy and
is suitable to almost any territory: Automatically steered
kites drag grounded cars running on a rail system in a
closed loop. A feasibility study for BMW (plant Leipzig)
showed that a NTS X-Wind-plant (speak: Crosswind) is at
least 3x more efficient than a common windmill, that the
capacity of utilization is approx. 90%, that X-Wind plants
are suitable to nearly any territory and that they can produce nearly basload energy for lesser costs than fossil fuels. Some figures: a common windmill has 1.900 fuel load
hours at Leipzig, NTS X-Wind plants 4.650! A test track of
400m has been established at northern Germany.
Page 154
Guido Luetsch, Managing Director:
born 1965; business administrator
(lic.oec, University of St. Gallen, Switzerland); 16 years of experience in
managing medium-sized companies
and project management for global
players (Kraft Foods, Volkswagen,
Schering AG).
Guido Lütsch
MAMA Sustainable Incubation AG (with cornerstone
investor 3M): 20%, KfW: 17,5%, Uwe Ahrens: 50,5%,
Guido Lütsch: 9%, Others: 3%. Round B: NTS is looking for
an investment of 13 m€ to finance a X-wind plant to generate
40 GWh/year. Subsidies are likely. Current investors will
invest as well.
Omikron Data Quality GmbH
Software
Profile
Number of employees
Equity (in m€)
1988
91
1.7
3.0
2005
4.6
5.4
6.5
10.6
Contact
Contact person
Phone
E-mail
Website
Address
Carsten Kraus
+49-(0) 72 31-1 25 97-1 25
[email protected]
www.fact-finder.com
Habermehlstr. 17
75172 Pforzheim
Germany
Semantic Search is globally considered the next level of
search technology. Our invention, the probabilistic inference engine, allows a better understanding of ambiguous
human input, and thus produces even better search results.
We have chosen the online travel industry as our first target
market, as travel has a global revenue of 630 bnUS$ dollars
and is the largest single eCommerce segment.
Management
CEO Carsten Kraus co-founded Omikron in 1988 and set
up FACT-Finder in 2001. The research team is headed by
mathematician Emin Karayel. The Development and technical teams are lead by Siegfried Schüle, CFO Siegfried
Raisin joined in 2010. The sales force for Germany is headed by Mathias Duda, international business is developed
by Katrin Jähnke.
Business Field
FACT-Finder is an innovative technology for Search & Navigation in webshops. By using FACT-Finder, online shops
have measured to increase their revenue by 10-33%. We
provide FACT-Finder mainly in an SaaS model, over 70% of
our revenue is recurring.
Carsten Kraus, CEO
This year, we have finished a new semantic search technology, which finds its first application in the largest online
shopping segment: Travel.
51 of Germany’s top100 online shops, in total more than
1,000 online shops in 26 countries rely on FACT-Finder –
this makes us the European market leader with approx.
30% market share. Each month, FACT-Finder processes
over 300 million search queries, which is about 7% of
Microsoft Bing’s world wide volume.
Siegfried Raisin, CFO
The company is 100% owned by the founders and some
employees. Omikron intends to raise a significant amount
of equity, first to conquer 20% of the global travel portals,
then to generally roll out the revolutionary semantic technology globally.
Platin Delikatessmanufaktur GmbH
Food
Profile
Business Field
Number of employees
Equity (in m€)
2011
35
0.60
2.50
2012
0.00
0.00
1.00
10.00
Contact
Delicatessen for European Food Retail. Customerfocussed White-Labels are offered.
The German Anti-Pasti market is dominated by a few
producers. The Platin Delikatessmanufaktur GmbH is a
start-up in this market segment, which has taken over an
insolvent company, which was active in this market
segment since the beginning of the century.
Management
Contact person
Phone
E-mail
Website
Address
Michael Peter
+49-(0) 70 32-2 03-0
[email protected]
www.delikatessmanufaktur.com
Bonner Str. 5
14197 Berlin
Germany
Michael Peter, Founder
Gordon Finlay, CEO (from 01.01.2012)
Markus Fauser
Planned 6.50 m€ new investment in East Germany in 2012
Now: production is located near Stuttgart/Tuebingen for the
new production we are looking for an investment with the
minimum volume of 2.50 m€
Markus Fauser
Page 156
REVOTAR Biopharmaceuticals AG
Biotechnology
Profile
Number of employees
Equity (in m€)
2000
15
10.5
25
-
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Martin Pöhlchen
+49-(0) 33 02-2 02 50-41
[email protected]
www.revotar.com
Neuendorfstr. 24 a
16761 Hennigsdorf
Germany
Revotar’s clinical pipeline is based on the lead compound
of Bimosiamose. The small-molecule active ingredient is
the world’s most developed selectin antagonist for respiratory diseases. As a pan-selectin antagonist, Bimosiamose
is directed at the various targets of the selectin family (E, P
and L selectin), which play a central role in the development, perpetuation and worsening of inflammatory diseases. Given its entirely new, selectin-antagonist active
principle, Bimosiamose represents one of the few promising therapy approaches that make a causal fight against
inflammatory pulmonary diseases possible. In addition,
Revotar’s pipeline consists of a new generation of selectin
antagonists in the pre-clinical stage, which were developed
using the company’s own technology platform (Rational
Drug Design).
Management
Dr. Martin Pöhlchen, CEO, former Pieris, MediGene, Tripos
Ludwig Felber, CFO, former Viscardi, Cowen, HVB
Prof. Dr. Wolfgang Meyer-Sabellek, CMO, former Charité,
AstraZeneca, Boehringer Mannheim
Business Field
Revotar is a privately owned biopharmaceutical company
headquartered in Hennigsdorf near Berlin, which specialises in the development of innovative drugs for the treatment of chronic and acute inflammatory diseases. The
research and development activities focus on anti-inflammatory small-molecule active ingredients for the treatment
of severe respiratory diseases with a high medical need and
an insufficient therapy. The two core areas of the clinical
product portfolio are chronic obstructive pulmonary
disease (COPD) and acute lung injury (ALI/ARDS). The
company pursues the development of its own therapeutic
projects until completion of clinical phase II in order to
supply attractive active ingredient candidates with clinically
proven efficacy and resilient, high sales expectations for
licensing out to pharmaceutical companies.
Dr. Martin Pöhlchen, CEO
Ludwig Felber, CFO
bmp, BFB Brandenburg, ANZ Nomineees, IBG, MVC
RIEMSER Arzneimittel AG
Pharmaceuticals
Profile
Business Field
Number of employees
Equity (in m€)
1991
600
52
1991
103
115
-
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Michael Mehler
+49-(0) 3 83 51-76-59
[email protected]
www.riemser.com
An der Wiek 7
17493 Greifswald-Insel Riems
Germany
RIEMSER Arzneimittel AG is a mid-sized specialty pharmaceutical company that markets primarily branded specialty/niche products for the area of Human Rx Specialties.
The Company has a direct sales presence in Germany,
France and the US with a rapidly growing presence internationally, selling into more than 80 countries worldwide.
RIEMSER is an international specialty pharmaceutical company, focussed on attractive niches in selected therapeutic
areas with high medical need, blending hands-on Mittelstand-culture with top industry processes and standards,
thereby delivering sustained top-tier growth rates, driven by
targeted acquisitions, organic growth and geographic
expansion. Key strategic areas comprise oncology, dermatology, antiinfectives and oral surgery technologies.
Management
Dr. Michael Mehler, Chief Executive Officer, joined
RIEMSER in 2009. He has more than 20 years of industry
experience in leading pharmaceutical and biotech companies. Dr. Mehler managed worldwide successfully blockbuster and specialty/niche product portfolios.
Beatrice von Buchwaldt joined RIEMSER in 2011 as Chief
Financial Officer. She brings 25 years of experience in
senior finance positions in a broad spectrum of industries
ranging from consumer goods to finance to biotech/pharma/healthcare.
Dr. Michael Mehler, CEO
Page 158
Beatrice von Buchwaldt, CFO
59.4% of the shares are held by the Braun Family, founders
of the company. The remaining shares are held in equal
parts by General Electric Equity and TVM Capital.
Sana Kliniken AG
Healthcare
Profile
Number of employees
Equity (in m€)
Management
1976
22,483
413.2
1,254
1,484
-
Dr. Michael Philippi, CEO
Thomas Lemke, CFO
Jan Stanslowski, management board member HR
Dr. Markus Müschenich, management board member
Medicine
Financing requirements
The financing requirements comprise transactions and
investment.
Contact
Contact person
Phone
E-mail
Website
Address
Thomas Lemke
+49-(0) 89-67 82 04-1 15
[email protected]
www.sana.de
Oskar-Messter-Str. 24
85737 Ismaning
Germany
Majority shareholders/Investors
Sana is owned by 31 leading private health insurance companies. The majority share-holders consist of the DKV (21,7%),
Signal (14,5%), Allianz Private (13,8%), Continentale (10,1%),
Debeka (10,1%), Deutscher Ring (4,2%), Barmenia (3,7%),
and other private health insurance companies (21,9%).
Business Field
Apart from the core business area which is the acute medical care at over 50 different hospitals, the Sana Kliniken AG
focusses on hospitals that specialize in the following key
medicines: cardiovascular medicine, orthopaedics and
neurology. Rehabilitation hospitals and retirement homes
complete their medical services.
Dr. Michael Philippi, CEO
Thomas Lemke, CFO
The Sana Kliniken AG is the number four among Germany’s
private clinic groups. It ranks among the top five private
European market leaders.
SemiLev GmbH
Semiconductors
Business Field
Profile
Number of employees
Equity (in m€)
2010
6
0.7
3
2014
0.4
SemiLev develops and markets Equipment Frontend
Modules (EFEMs) and sorters for wafer-handling in the
semiconductor industry. The heart of these products is a
proprietary technology platform based on contactless
bearings made practical for wafer-handling for the first
time. This constitutes a decisive step toward completely
contamination- and wear-free wafer processing in a chip
factory. Even energy- and data-transfer processes are
executed without contact.
Contact
Contact person
Phone
E-mail
Website
Address
Willi Rugen
+49-(0) 60 22-2 61-8 00
[email protected]
www.semilev.de
Industriering 7
63868 Grosswallstadt
Germany
SemiLev has entered the handling equipment market with a
new protected proprietary technology which gives the
company a clear USP. SemiLev’s products help its customers to significantly improve the yield in computer chip
production and reduce total cost for equipment ownership.
Management
SemiLev is lead by a high profile management team.
Willi Rugen (56), chief sales and finance officer, looks back
to 30 years management experience in sales and finance. In
his career he several times successfully built up and grew
new business units and lead larger entities with a multi bn€
business volume. Willi holds a Master degree in economics.
Dr. Ulrich Oldendorf (46), chief technology officer, started
his career as an assistant professor and then founded and
successfully developed a business in the field of mechatronics. Ulrich holds a PhD in mechanical engineering.
SemiLev is seeking a funding commitment of 3 m€ for the
expansion of its sales and service organization, assembly
facilities and further R&D.
Willi Rugen
Page 160
Dr. Ulrich Oldendorf
Signature Diagnostics AG
Biotechnology
Profile
Number of employees
Equity (in m€)
2004
33
7.9
15
1.6
0.6
0.4
1.9
Contact
Contact person
Phone
E-mail
Website
Address
Prof. Dr. André Rosenthal
+49-(0) 3 31-20 00-2 01
[email protected]
www.signature-diagnostics.de
Hermannswerder 20a
14473 Potsdam
Germany
a focussed commercialization strategy targeting six key
metropolitan markets. The Company is currently evaluating
its regulatory and commercialization strategy in the United
States and has the potential to launch Detector C alone or
with a strategic partner as a laboratory developed tests
(LDT) in early 2013 or as a FDA-approved test in 2014.
Large market opportunity with significant growth potential;
Detector C is a game changing diagnostic product for early
CRC screening;
strong value proposition of Detector C will drive adoption;
deep pipeline of earlier stage product candidates to drive
long-term growth;
strong IP position provides competitive advantage and
creates barrier to entry.
Management
Prof. Dr. André Rosenthal, CEO
Dr. Rainer Kramer, CBO
Business Field
Signature Diagnostics AG is a molecular diagnostics company that discovers, develops and commercializes innovative
in vitro diagnostic tests to detect cancer at an early stage,
predict the prognosis of cancer patients and predict the
drug response of cancer patients. The Company’s lead product, Detector C, is best-in-class non-invasive blood-based
test for the early detection of colorectal cancer (CRC). The
CRC screening market remains largely underpenetrated
given the low compliance rates, and as such, the Company
believes the market has significant potential to grow with
the launch of Detector C. Signature intends to target the
non-compliance segment of the market and projects the
global market opportunity for Detector C to be approximately 5 bnUS$ by 2018. The Company projects its revenues in the US and Germany to reach 1.3 bnUS$ by 2018, representing 25% market penetration. The Company intends
to launch these products in Germany in early 2012 utilizing
Prof. Dr. André Rosenthal, CEO
Dr. Rainer Kramer, CBO
Financing need: 20 m€;
VC investors: 61%, private investors: 13%, management:
26%
SIRION BIOTECH GmbH
Biotechnology
Profile
Number of employees
Equity (in m€)
2006
11
2.3
2.5
2013
0.263
0.445
0.450
0.700
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Christian Thirion
+49 (0)-89-70 09 61 99-15
[email protected]
www.sirion-biotech.de
Am Klopferspitz 19
82152 Martinsried
Germany
Today, most industrial and academic cell line development
is made in-house; such captive in-house development presents the main competition to SIRION BIOTECH.
With its focus and commitment, its vast technology platforms
and its long standing experience, SIRION BIOTECH’s Cell
Competence Center presents an attractive alternative for
clients to outsource such development for effectiveness and
efficiency. In addition, outsourcing as a trend is accelerating
to allow clients to focus on their core capabilities. As a consequence, leading European drug discovery companies like
Bayer and Merck are on SIRON BIOTECH’s client list and
entertain framework service agreements.
Management
SIRION BIOTECH was founded in 2006 by Dr. Christian
Thirion, a renowned expert in cell line development. He
serves as its Chief Technology Officer. Chief Operating Officer
is Dieter Lingelbach, a sales & marketing professional with
many years of leadership and management experience at
Roche Diagnostics/Roche Applied Science and MorphoSys.
Business Field
SIRION BIOTECH is a technology leader in the field of
functional gene analysis and cell models for basic research,
drug and compound development. The company serves
leading European and Japanese Drug and Biotech companies as a provider of latest technologies for them to advance identification of novel compounds and target validation.
SIRION BIOTECH has over the years developed vast virus
platform technologies that allow for effective knockdowns
and overexpression of target genes. With its proven RNAi
validation system, SIRION BIOTECH is able to achieve gene knockdowns of about 90% thus outperforming current
industry standards by multiples. In only 6 weeks SIRION
BIOTECH can provide for new custom-made cell pools.
With its set of skills and technologies, SIRION BIOTECH
contributes significantly to the shortening of pre-clinical development cycles.
Page 162
Dr. Christian Thirion
Dieter Lingelbach
SIRION BIOTECH is funded by Creathor Venture, Bayern
Kapital, KfW & HTGF. It seeks funding for further rolling out
its business model into the North American and Japanese
markets and to leverage its base technologies for related
ready-to-go high value products suitable for outlicensing.
SUNOVA AG
Renewable Energies
Profile
Management
Number of employees
Equity (in m€)
2008
25
1.8
10
2009
9
21
10
13
Werner Innerhofer, CTO (Chairman)
Werner Hillebrand-Hansen, CTO
Stockholders:
- Hans Steinbronn
- Werner Innerhofer
- Werner Hillebrand-Hansen
- Marino Fantin
- Hans-Dieter Broschwitz
Contact
Contact person
Phone
E-mail
Website
Address
Werner Innerhofer
+49-(0) 89-1 89 04 73-72
[email protected]
www.sunova.eu
Bretonischer Ring 11
85630 Gransbrunn
Germany
Financing requirement 10 m€:
Mezzanine capital for a solid equity base for development
of the SUNOVA Smart Energy business sector, investment
and operation of solar plants
Business Field
Solar power stations on industrial and commercial flat
lightweight roofs
SUNOVA is specialist for solar power stations on industrial
and commercial flat lightweight roofs. In the installation of
solar power stations, the company unites expertise in flat
roof and solar technology, using in-house-developed fixing
methods for solar generator and roof sealing.
USPs:
• Roof solar installation from a single source
• Flat roof compatible solar technology
• 20 years stability guarantee
Werner Innerhofer, CEO
Werner Hillebrand-Hansen, CTO
Superwise Technologies AG
IT-Services
Profile
Number of employees
Equity (in m€)
2007
15
2
3.5
2012
0.25
1.0
0.6
3.0
Contact
Contact person
Phone
E-mail
Website
Address
Dr. jur. Ernst Pechtl
+49-(0) 81 71-9 69 69-0
[email protected]
www.superwise-technologies.com
Bahnhofstr. 26
82515 Wolfratshausen
Germany
proprietory technology, Superwise provides meaningbased speech analysis and thus offers technology for comprehensive video search. This technological edge is enhanced
by user-friendliness: Superwise’s software is capable of
learning: the training material simply has to be imported,
learning is performed fully automatically – and fast. No
programming is required. Among the numerous possible
market segments Superwise has decided for media and tv
(video analysis in the fields of medicine is economically
most interesting and can be licensed). Currently, a beta
version is implementation for a global satellite company. All
available data indicate Superwise’s excellent position as
comparable solutions are hardly offered. There is a keen
interest for this solution. In order to serve the market an
investment in personnel and infrastructure is required,
which should essentially be covered by capital injection.
Management
Dr. jur. Ernst Pechtl, CEO
Torsten Dobroschke, Head of Development
Supervisory Board: RA Dr. Oliver Maaß, Dr. Robert Zores,
Heiko Eckelt
Business Field
Development and distribution of software for the search in
and the analysis of multimedia data, especially in large
archives of media companies, A/V archives and organizations right up to realtime scene-analysis of supervisory video
cameras.
Dr. Ernst Pechtl, CEO
Currently images and videos can hardly be searched for
their content. Instead, only a keyword search can be carried
out, provided the searched images are tagged. Therefore,
only tagged content can be found. The same is true for
videos, drawings and the like. But the market urgently calls
for real image search and analysis. Superwise presents for
the first time a REAL image search: a search engine for the
content of digital images and videos. Video search/analysis
requires analysis of the sound track, too. With similar,
Page 164
Ca. 3,5 m€. Assignment: productization, sales infrastructure,
extension of development capacities, broadening of IP.
Founder Dr. Ernst Pechtl: ca. 75%, investors: ca. 25%
Targos Molecular
Pathology GmbH
Biotechnology
Profile
Number of employees
Equity (in m€)
2005
65
1.95
5
2005
4.3
4.7
5.0
5.4
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Thomas Henkel
+49-(0) 5 61-5 00 45-3 00
[email protected]
www.targos-gmbh.de
Germaniastr. 7
34119 Kassel
Germany
currently 700 mUS$, plus an additiona 300 mUS$ for
reference testing in regions with insufficient access to biomarker testing but need for targeted therapies. A market
share of 5-10% will offer a revenue potential of up to 100
mUS$. The Targos USP is the know-how with large and complex international biomarker trials and IVD approval studies
and the large and experienced pathology team.
Management
Targos founders and top management represent the companies core expertise: Dr. Thomas Henkel (CEO) enjoys a
20-year experience in the biopharmaceutical industry as
entrepreneur, innovation manager and research director
(MediGene, Tularik). Prof. Josef Rüschoff (Chief Medical
Officer) is one of Germany’s most dynamic clinical & molecular pathologists. He gained international reputation by
10-years of achievements in the clinical testing of predictive
biomarkers. He is on the SABs of Roche, Merck-Serono
und DAKO.
Business Field
Targos Molecular Pathology GmbH is a preferred provider
for clinical biomarker services. The main product is highly
standardized biomarker analytics under GCP conditions
combined with project-logistics and data management.
Our daughter company Targos Advance AG offers training
& education, consulting, marketing support und reference
testing for the industry. The R&D daughter Targos Development AG develops an own portfolio of proprietary biomarkers and targets and offers the industry co-development of
companion diagnostics.
The global market for next generation cancer diagnostics is
currently 776 mUS$, reachin up to 5 bnUS$ in 2015. Targos
cooperates with 6 of the Top 15 Global Industries. The market potential for biomarker services for industry customers is
Dr. Thomas Henkel, CEO
Prof. Josef Rüschoff, CMO
Establishment of tele-pathology and new Targos locations
(Cologne, potentially US, Brazil, China), strengthening of
marketing activities (web-presentation, congresses),
expansion of the reference testings in Latin America and
Middle East. Planned investments of about 5 m€, for organic
growth. For accelerated growth by acquisition higher
investments are foreseen.
Torqeedo GmbH
Profile
Business Field
Number of employees
Equity (in m€)
2005
36
5.0
2013
5
6.3
9.2
13
Contact
Website
Address
www.torqeedo.com
Petersbrunner Str. 3a
82319 Starnberg
Germany
Torqeedo is the global leader in e-mobility for boats, focussing on electric outboards.
Torqeedo outboards convert limited battery supply better
into propulsive power than any other outboard on the market. In addition, they offer product-specific advantages like
ultra-lightweight design, integrated GPS-based range calculation, competitive price-points etc. Drivers for Torqeedo’s unique performance are unique technological advantages with regards to module-technologies (motor-, battery-,
propeller-technology) as well as system-technologies (e.g.
safety, user-interface, corrosion resistance). Torqeedo is
leveraging the unique product advantages to build an international consumer brand for clean outboards. As the global
pioneer in this field, Torqeedo stands already today for
clean high-tech drives with superior performance.
Management
Christoph Ballin, Co-Founder and Managing Director
– prior positions include
Managing Director Gardena
Deutschland GmbH, Corporate Sales Director Gardena
AG, Engagement Manager
McKinsey & Company Inc.
Christoph Ballin
Photo: Torqeedo GmbH
Main current investors: Wheb Ventures, Brose Trust AG,
Extorel AG
Page 166
van den Berg AG
Software
Profile
Number of employees
Equity (in m€)
1986
58
1.2
4.0
2007
3.9
4.1
4.1
10.0
Contact
Contact person
Phone
E-mail
Website
Address
Hans-Rainer van den Berg
+49-(0) 24 06-9 54-5 50
[email protected]
vdb.de
Im Strasser Feld 3
52134 Herzogenrath
Germany
The costs for the SEPA implementation of the bank customers are expected to be a double-digit billion amount.
The introduction of SEPA at bank customers is a project,
which goes far beyond the accounts department. Affected
are the managements department, the staff department,
treasury, the legal department, marketing, IT, the sales
department, the mail-administrating department, archive/
research and the customer service. For that reason the
implementation of the vdb/SSC will be accomplished
through experienced consulting partners (as e.g. cirquent,
C1FinCon, Pass Consulting).
Management
Hans-Rainer van den Berg, CEO
G.-D. van den Berg, Authorized Representative
A. Frank, G. Wöbken, Authorized Representatives
Business Field
Since 25 years the van den Berg AG (vdb) stands for innovative solutions in the field of payment transactions – development, distribution, support and finally operating of a
SWIFT Service Bureau. By now, vdb’s SEPA solutions are
implemented since four years at banks, as e.g. at the
Oldenburgische Landesbank, ING DIBa, National Bank and
the Wüstenrot Bank.
Hans-Rainer van den Berg
The activities concerning the SEPA development started in
2006 with the SEPA Credit Transfer (SCT). In the following,
solutions for SEPA Direct Debit (SDD) and mandate management for debtor banks were developed. With the planned EU-regulation, the adoption of SEPA-payments also for
bank customers (corporates) will become obligatory. Van
den Berg has extended its SEPA-solutions for banks in respect to the needs of the bank customer.
4 m€
H.-R. van den Berg and G.-D. van den Berg
VESTOLIT GmbH & Co. KG
Chemicals, Commodity
Profile
Number of employees
Equity (in m€)
1994
560
40
30
2011
344
404
462
513
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Michael Träger
+49-(0) 23 65-49-55 12
[email protected]
www.vestolit.de
Paul-Baumann-Str. 1
45772 Marl
Germany
VESTOLIT has long-term relationships with its customers
offering them advantages that few or none of our competitors can provide. We generally target higher value-added
specialised PVC products such as paste PVC which protects us from the cyclicality of PVC prices. The Monomers
business is predominantly focussed on lowest cost to supply our downstream processes. In addition to that it excels
in the production of specialty chlorine derivative products
such as Ethylchloride, where we are Europe’s only producer, and Methylchloride where we are number 2 in Europe’s
merchant market. Our monomer plants also form an essential part of the production of the chemical park in Marl
where we are supplying basic chemicals and offering
production services to other chemical companies.
Management
Dr. Michael Träger, Managing Director, CEO, Thomas
Dötsch, CFO, Dr. Michael Beziel, VP Operations Monomers, Dr. Dieter Polte, VP Operations Polymers, Dr.
Thomas Neu, Marketing Monomers, Hans-Christoph
Porth, Marketing Polymers, Dirk Weinmann, Production
Services, Martin Rath, Human Resources
Business Field
VESTOLIT is a major European manufacturer of PVC and
operates Europe’s largest fully integrated plant for PVC production. VESTOLIT targets specialised PVC products and
has a leading European market share for HIS-PVC and
paste PVC. Our site at the chemical park in Marl, Germany,
provides us with lowest costs thereby enhancing our competitiveness. The business is managed through three product divisions: Extrusion PVC which produces predominatly HIS-PVC for window profiles; Paste PVC which produces
grades for the automobile industry, flooring, wall coverings
and coated fabric products; and Monomers which produces
chlorine, caustic soda and other chlor-alkali products which
are sold to industrial organic and inorganic chemicals
customers.
Dr. Michael Träger, CEO
Private Equity owned
(Strategic Value Partners)
Page 168
Thomas Dötsch, CFO
VST Verbundschalungstechnik GmbH –
VST Group
Construction material
Profile
Number of employees
Equity (in m€)
2002
230
6.6
5.0 – 10.0
2005
9.9
18.8
24.0
30.0
Contact
Contact person
Phone
E-mail
Website
Address
Dr. Michael Müller
+43-(0) 66 44 64 03 [email protected]
www.vst-austria.at
Feuerwehrstr. 17
2333 Loepoldsdorf
Austria
Industrialized construction methodology: More than 50%
of construction work is relocated to the production facilities
of the own VST fabric.
Tow business fields: 1.) Formwork system for construction
companies 2.) Technology & License Business
Regional market leadership is already achieved in cooperation with a world market leading company in construction
business, SKANSKA AB of Sweden in the multi-storey buildings market of Sweden. VST system meets all mega
trends in construction as the Green Building Trend, Fast
Speed Construction, Off-site construction methodology
and Freedom of Design. Set of IPs and production know
how allow protection of a sustainably increasing market
position.
Management
Well approved technical as well as financial capabilities.
Audited consolidated annual reports since 2008 based on
IFRS standard. Complete management team at best age
consists of CEO/CFO (founder), COO and CTO. All with
academic degrees.
Business Field
A world market product in construction material as Green
Building Technology component. Patent protected VST
permanent formwork system meets worldwide standards
and allows every local design and type of building. VST
industrially manufactured formwork forms after poured with
self compacting concrete at the construction site, a fully
loadbearing shell of any user-defined structural design.
VST system saves 50% of construction time and offers
superior building features. Strong Clean Tech profile:
highest thermal insulation standard. Certified Passive
House component. Allows lowest running costs over life
cycle of buildings because of significant energy savings
and minimal maintenance level for the shell, approved by
life cycle assessments. Minimal construction waste saves
costs of site cleaning and disposal and protects environment. High accuracy & precision offer best of class construction quality. No internal or external plasterwork necessary.
Mag. Dr. Michael Müller
Ing. Siegfried Gassner
Capital need is is at least 5 m€ up to 10 m€ in a first finance
round. An IPO is considered over the next two years. Company is fully owned by the Founder and CEO.
Windreich AG
Renewable Energies
Profile
Business Field
Number of employees
Equity (in m€)
1999
100
142
75-100
1999
113
125
150
>200
Contact
CContact person
Phone
E-mail
Website
Address
Matthias Hassels
+-(0) 70 22-95 30 60
[email protected]
www.windreich.ag
Esslinger Str. 11-15
72694 Wolfschlungen
Germany
The Windreich AG is one of the leading pioneers in the development of wind energy. The company was found in 1999
and has since then; built, financed, and operated more than
1000 wind turbines (2000 MW). After successfully testing
the possibilities of onshore wind, the Windreich AG decided
to expand its field of business to include the construction
and management of large offshore wind parks. Again, the
Windreich AG found itself in a leading role in the expansion
of this new market segment which is rapidly growing. Because of its unique market position, the Windreich AG will
once again have a leading role in one of the major developments in renewable energies.
Through the company’s extensive experience in the development of onshore wind, the Windreich AG was able to secure a key market advantage by securing limited property
and building rights for offshore wind parks. According to an
industry report, the Windreich AG has secured property
rights for 40% of all possible offshore wind park projects in
the German North Sea. Windreich’s first offshore wind park,
Global Tech I consists of 80 wind turbines each with a capacity of 5 MW. The project is running on-time and is expected to be connected to the grid in 2012. Due to Windreich’s
extensive project pipeline, the company plans to realize one
offshore wind park annually.
Management
Willi Balz, CEO and sole shareholder
Dr. Walter Döring, Chairman of the Board
Heiko Roß, Director of Technology
Matthias Hassels, Chief Financial Officer
Willi Balz, CEO
Page 170
Dr. Walter Döring,
Chairman of the Board
Funding requirements exist on two levels:
project level (1.7 bn€ total investment volume, 1/3 equity,
2/3 financing)
corporate level (financing for upfront investments made by
the Windreich AG to secure the offshore project pipeline)
Zimory GmbH
Software
Profile
clouds, test & lab clouds and enterprise IT consolidation
across multiple sites, while avoiding costly lock-in.
Number of employees
Equity (in m€)
2007
30
-
Ruediger Baumann, CEO Maximilian Ahrens, CPO
Contact
Contact person
Phone
E-mail
Website
Address
Maximilian Ahrens
+49-(0) 30-6 09 85 07-18
[email protected]
www.zimory.com
Revaler Str. 100
10245 Berlin
Germany
Business Field
Zimory provides dynamic, independent and elastic cloud
management software that enables Enterprise Companies
and Service Providers to transform their virtualized data
centers into Cloud Services infrastructures and Cloud
Service Provider’s to set up and offer high quality Infrastructure as a Service (IaaS).
Prof. Dr. Gustavo Alonso,
CTO
Management
Ruediger Baumann, CEO, brings to Zimory a wealth of
experience and expertise, with more than 30 years of
knowledge within the IT and communications industries.
Prior to Zimory, Ruediger successfully served in well-known
enterprises like Philips and ADC, and start-ups that have
included British Telecom spin off companies.
Maximilian Ahrens, CPO, is a frequent speaker at international conferences for service oriented architecture and virtualization. Prior to co-founding Zimory, he served as a
research scientist at the innovation development laboratory
at Deutsche Telekom.
Prof. Dr. Gustavo Alonso, CTO and professor at Swiss
Federal Institute of Technology Zurich (ETH), brings extensive experience in databases, enterprise application integration, transaction processing, data replication and
middleware platforms.
Zimory’s _Carrier Grade_ Cloud product suite delivers a
secure, fully flexible, scalable and interoperable, end-toend solution for private, public, hybrid and database cloud.
Zimory’s IaaS cloud management software is a strong complement to CloudFactory’s capabilities. Its user friendly,
self-service portal enables customers to rapidly deploy and
manage solutions for service providers, development
Funding round scheduled for Q2/2012.
Investor Creathor Venture is personal referral.

Cytolon AG - Deutsches Eigenkapitalforum

Transcription

Similar documents

Conference Magazine 2012 - Deutsches Eigenkapitalforum

Lebensmittel-Onlinehandel in Deutschland

FAISALABAD ELECTRIC SUPPLY COMPANY LIMITED /./)-- —

Conference Magazine 2011 - Deutsches Eigenkapitalforum

Annual Report 2014 - Investor Relations Center

Snowbird AG

Conference Magazine 2013 - Deutsches Eigenkapitalforum

Mittelstandstag Rheinland-Pfalz - LBBW Rheinland